Curated Wealth Partners LLC Novartis Ag Transaction History

Curated Wealth Partners LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 23, 2023	SELL	$94.73 - $105.13 $116,233 - $128,994	-1,227 Reduced 29.44%	2,941 $299,000
Q1 2023 Apr 27, 2023	SELL	$80.03 - $92.81 $22,888 - $26,543	-286 Reduced 6.42%	4,168 $383,000
Q4 2022 Jan 30, 2023	SELL	$75.55 - $92.52 $57,493 - $70,407	-761 Reduced 14.59%	4,454 $404,000
Q3 2022 Oct 13, 2022	SELL	$74.61 - $87.26 $74,908 - $87,609	-1,004 Reduced 16.14%	5,215 $396,000
Q2 2022 Jul 27, 2022	BUY	$80.52 - $93.75 $500,753 - $583,031	6,219 New	6,219 $526,000
Q4 2021 Feb 03, 2022	SELL	$79.7 - $88.13 $423,047 - $467,794	-5,308 Closed	0 $0
Q3 2021 Nov 08, 2021	BUY	$81.78 - $95.14 $65,178 - $75,826	797 Added 17.67%	5,308 $434,000
Q2 2021 Aug 11, 2021	BUY	$85.24 - $94.15 $1,790 - $1,977	21 Added 0.47%	4,511 $412,000
Q1 2021 May 14, 2021	SELL	$83.5 - $98.47 $14,863 - $17,527	-178 Reduced 3.81%	4,490 $383,000
Q4 2020 Feb 16, 2021	BUY	$78.07 - $94.43 $364,430 - $440,799	4,668 New	4,668 $441,000

1,437

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $223B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Curated Wealth Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Curated Wealth Partners LLC with notifications on news.